Current Studies

Study Information
Location
Status
Age Range
Sex
Max Compensation
ADHD (child)
A placebo controlled study evaluating the efficacy and safety of an investigational medication for Children with ADHD
Evansville
Owensboro
Enrolling
4-5 yrs
Male/Female
Up to $1900
COPD
A phase III study to evaluate the efficacy and safety of an investigational medicine in adult participants with moderate to very severe chronic obstructive pulmonary disease.
Bowling Green
Owensboro
Enrolling
40-80 yrs
Male/Female
TBD
COPD and Chronic Bronchitis
A 52-week study to evaluate the efficacy and safety of two doses of an investigational medicine in subjects with Chronic Obstructive Pulmonary Disease (COPD) and chronic bronchitis.
Bowling Green
Enrolling
40+ yrs
Male/Female
TBD
LIPOPROTEIN (a)
A study to investigate the effect of an investigational medicine on the reduction of major adverse cardiovascular events in Adults with Elevated Lipoprotein(a)
Bowling Green
Enrolling
18+ yrs
Male/Female
Up to $2150
MIGRAINES IN CHILDREN
A double blind, placebo controlled study of an investigational medicine for Pediatric Migraines
Bowling Green
Evansville
Owensboro
Enrolling
6-17 yrs
Male/Female
$200/$350
OBESITY + CKD
A study to evaluate the efficacy of a once weekly investigational medicine for adults living with obesity and chronic kidney disease with or without T2DM.
Bowling Green
Evansville
Enrolling
45+ yrs
Male/Female
Up to $3600
ATOPIC DERMATITIS (Eczema)
A phase 2 study of the effects of an investigational medicine in adults with moderate to severe atopic dermatitis
Owensboro
Coming Soon
18-75 yrs
Male/Female
TBD
Dyslipidemia and CV Risk
A phase III study to assess the effect of an investigational medicine on LDL-C patients with clinical ASCVD (atherosclerotic cardiovascular disease) or at risk for a first ASCVD event
Owensboro
Coming Soon
18+ yrs
Male/Female
TBD
ASCVD and Elevated LDL
A phase III study of an investigational medicine on major adverse CV events in patients with a history of ASCVD (atherosclerotic cardiovascular disease) events or at a high risk for a first event
Bowling Green
Evansville
Owensboro
Coming Soon
18+ yrs
Male/Female
TBD
ASCVD
A phase III study to evaluate the efficacy and safety of investigational medicines compared with placebo in participants with type 2 diabetes, hypertension and established cardiovascular disease
Bowling Green
Coming Soon
18+ yrs
Male/Female
TBD

Contact Us

Pin It on Pinterest